Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 70.10
+0.60 (0.86%)
Nov 13, 2026, 1:30 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 109.03 billion as of November 13, 2026. It is the 4,747th most valuable company in the world and the 124th biggest in Taiwan. Its market cap has decreased by 43.30% in one year.
Market Cap
109.03B
Enterprise Value
105.44B
Revenue
15.98M
Global Rank
Country Rank
#124 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 109.03B, an increase of 1,270.04%. That is a compound annual growth rate of 96.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 109.03B | -54.62% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 148.84B |
| Pell Bio-Med Technology | 58.97B |
| Oneness Biotech | 24.07B |
| Sunmax Biotechnology | 20.94B |
| Steminent Biotherapeutics | 18.61B |
| TaiMed Biologics | 17.57B |
| EirGenix | 16.61B |
| Gongwin Biopharm Holdings | 16.59B |